The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression

被引:5
作者
Hudson, Careen L. [1 ,2 ]
Zemlin, Annalise E. [1 ,2 ]
Ipp, Hayley [2 ,3 ]
机构
[1] Univ Stellenbosch, Div Chem Pathol, Dept Pathol, ZA-7505 Tygerberg, South Africa
[2] Tygerberg Hosp, NHLS, Cape Town, South Africa
[3] Univ Stellenbosch, Div Haematol, Dept Pathol, ZA-7505 Tygerberg, South Africa
关键词
Cardiovascular risk; HIV infection; inflammation; endothelial dysfunction; T-CELL-ACTIVATION; MYOCARDIAL-INFARCTION RATES; C-REACTIVE PROTEIN; ANTIRETROVIRAL THERAPY; ADENOSINE-DEAMINASE; PLASMA-CONCENTRATION; ARTERY-DISEASE; MORTALITY; PREDICT; EVENTS;
D O I
10.1177/0004563213505848
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: As lifespan in HIV infection increases, cardiovascular disease has emerged as a cause of morbidity and mortality. Asymmetric dimethylarginine is an established marker of endothelial dysfunction and predicts cardiovascular events. The role of asymmetric dimethylarginine in HIV-related cardiovascular disease has not been established. Our aim was to determine whether asymmetric dimethylarginine concentrations were elevated in treatment naive, HIV-infected subjects and to correlate these with markers of immune activation and disease progression. Methods: Serum samples were collected from HIV-positive and -negative subjects attending a primary health care clinic over a 12-month period. Asymmetric dimethylarginine concentrations were measured and correlated with CD4 count, viral load, hsCRP, IL-6, IgG, adenosine deaminase and CD8/38 T lymphocytes. Results: Sixty HIV-positive participants (mean age 32.0 years) and 20 HIV-negative controls (mean age 32.4 years) were studied. All were of black ethnicity. The mean asymmetric dimethylarginine concentration in the infected group measured 0.67 mu mol/L (95% CI 0.62-0.72 mu mol/L) which was significantly higher than in the control group of 0.48 mu mol/L (95% CI 0.40-0.56 mu mol/L). Asymmetric dimethylarginine correlated inversely with CD4 counts and positively with IgG, adenosine deaminase and CD8/38 T lymphocytes. No significant correlation was found with hsCRP, IL-6, or viral load. Conclusion: We demonstrated that asymmetric dimethylarginine is elevated in HIV infection, in patients with relatively well-preserved CD4 counts not yet on anti-retroviral treatment. We showed significant correlations of asymmetric dimethylarginine with CD8/38 T lymphocytes, IgG and adenosine deaminase, suggesting that T-cell activation and the adaptive immune response underlie asymmetric dimethylarginine elevation in this population.
引用
收藏
页码:568 / 575
页数:8
相关论文
共 45 条
[1]   Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders [J].
Antonioli, Luca ;
Colucci, Rocchina ;
La Motta, Concettina ;
Tuccori, Marco ;
Awwad, Oriana ;
Da Settimo, Federico ;
Blandizzi, Corrado ;
Fornai, Matteo .
CURRENT DRUG TARGETS, 2012, 13 (06) :842-862
[2]   HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine, a Novel Marker of Endothelial Dysfunction [J].
Baker, Jason V. ;
Neuhaus, Jacqueline ;
Duprez, Daniel ;
Freiberg, Matthew ;
Bernardino, Jose I. ;
Badley, Andrew D. ;
Nixon, Daniel E. ;
Lundgren, Jens D. ;
Tracy, Russell P. ;
Neaton, James D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (02) :128-134
[3]   The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine [J].
Blackwell, Scott .
ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 :17-28
[4]   Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients [J].
Bofill, M ;
Mocroft, A ;
Lipman, M ;
Medina, E ;
Borthwick, NJ ;
Sabin, CA ;
Timms, A ;
Winter, M ;
Baptista, L ;
Johnson, MA ;
Lee, CA ;
Phillips, AN ;
Janossy, G .
AIDS, 1996, 10 (08) :827-834
[5]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[6]   PROGNOSTIC VALUE OF ADENOSINE-DEAMINASE COMPARED TO OTHER MARKERS FOR PROGRESSION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME AMONG INTRAVENOUS-DRUG-USERS [J].
CASOLI, C ;
LISA, A ;
MAGNANI, G ;
STARCICH, R ;
FIACCADORI, F ;
BERTAZZONI, U ;
ZEI, G .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (02) :203-210
[7]   Asymmetrical dimethylarginine - The Uber marker? [J].
Cooke, JP .
CIRCULATION, 2004, 109 (15) :1813-1818
[8]   Nitric oxide synthase: Role in the genesis of vascular disease [J].
Cooke, JP ;
Dzau, VJ .
ANNUAL REVIEW OF MEDICINE, 1997, 48 :489-509
[9]   Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection [J].
De Milito, A ;
Nilsson, A ;
Titanji, K ;
Thorstensson, R ;
Reizenstein, E ;
Narita, M ;
Grutzmeier, S ;
Sönnerborg, A ;
Chiodi, F .
BLOOD, 2004, 103 (06) :2180-2186
[10]   B lymphocyte dysfunctions in HIV infection [J].
De Milito, A .
CURRENT HIV RESEARCH, 2004, 2 (01) :11-21